The Scientist - Home

Mechanically sensitive proteins called gellins sense and respond to protoplasm flowing out of severed hyphae, quickly sealing up injuries in these root-like structures of fungi.

Outcomes in COVID-19 patients may be better in those recently infected with endemic coronaviruses. 

Two new medications for treating a rare and deadly neuromuscular disease have high prices and questionable efficacies, say scientists.

Jos Lelieveld of the Max Planck Institute for Chemistry explains how fine particulate might contribute to deaths from COVID-19.

Vaccine experts say the results surpass their expectations, but the study is not complete, and the data have not been peer reviewed.

Enhancers, short regions of DNA that direct gene expression, of species separated by 700 million years of evolution worked interchangeably, according to a new study.

A review offers a glimpse of previously unconsidered variables that could hinder efforts to identify true correlations between disease and gut microbiome composition.

Researchers propose that an infusion of memory T cells from people who have recovered from SARS-CoV-2 infections could treat severe disease.

Environmental engineer Gil Bohrer discusses how long-term, large-scale tracking data can shed light on the unexpected ways animals are responding to changes in the Arctic.

Government authorities say because the animals are good hosts of the novel coronavirus, and this new viral variant could undermine vaccine efforts against COVID-19, they are destroying the nation's entire stock of mink.

SARS-CoV-2, the virus that causes COVID-19, taps into human proteases such as furin to enter cells. Temporarily inhibiting those enzymes might stymie infection.

The study, published in a peer-reviewed journal, has attracted widespread derision from researchers.